Vanguard Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Vanguard Asset Management's WST Position: Q3 2026 in Review
Vanguard Asset Management increased its West Pharmaceutical (WST) stake by 8% in Q3 2026, buying an estimated $3.9M and bringing the position to 149,226 shares worth $55.3M. The position accounts for 0.03% of the portfolio, ranked #404.
Vanguard Asset Management first reported a position in WST in Q1 2026 and has held it in 3 quarters since. 789 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Vanguard Asset Management held 149,226 shares of West Pharmaceutical worth $55.3M as of Q3 2026.
- Vanguard Asset Management bought 11,036 West Pharmaceutical shares in Q3 2026, an estimated $3.9M.
- West Pharmaceutical made up 0.03% of Vanguard Asset Management's portfolio in Q3 2026, its #404 holding.
- Vanguard Asset Management first reported a position in West Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
- 789 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.